Navigation Links
Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
Date:9/4/2012

BILLERICA, Mass., Sept. 4, 2012 /PRNewswire/ -- Aushon BioSystems today announced that Martin Verhoef has been appointed Chief Executive Officer.  Mr. Verhoef has also been appointed to the Company's Board of Directors. Peter Honkanen, Founder and former Chief Executive Officer, will assume the Chief Operating Officer role and continue as a Board Director.

(Logo: http://photos.prnewswire.com/prnh/20120621/NE25431LOGO)

"We welcome Martin to Aushon and are especially excited about the extensive commercialization experience he brings to the organization.  Now that the company has achieved its product development milestones, it's sharpening its focus on the commercialization of its products.  With his background and experience, Martin offers the right leadership to realize the company's potential," commented Rich D'Amore, Founding Partner of North Bridge Venture Partners.

"I'm very excited to work with Martin and to shift my focus to further strengthening the Development and Operations teams as we prepare the organization for substantial growth," added Peter Honkanen.

Mr. Verhoef has a career of over 25 years experience in the life science research tools and molecular diagnostics business.  Prior to joining Aushon, Mr. Verhoef was Chief Executive Officer at the molecular diagnostic firms MiraDx and PrimeraDx. He was also a member of Ciphergen's executive team where he led the company's BioSystems Division. Mr. Verhoef has also held various senior management roles at Agilent in Germany and the US.  He holds BS degrees in Medical Chemistry and Chemistry from the van 't Hoff Institute in Rotterdam, The Netherlands.

"I am delighted to be joining Aushon at this stage of its development. The new Cira™ platform has been exceptionally well received and is already being adopted by key customers throughout the life science industry. I strongly believe that CiraPlex™ will become the platform of choice for protein biomarker analysis and will help drive personalized medicine," commented Mr. Verhoef.

About Aushon

Aushon BioSystems, Inc., provides a comprehensive suite of multiplex immunoassay products and services for protein biomarker discovery, development, and analysis to leading pharmaceutical, biotechnology, academic, and diagnostic clients worldwide. Our unique combination of proprietary microarray printing, extensive biomarker content, and our innovative Cira immunoassay platform deliver exceptional performance, quality, and reliability to accelerate preclinical and clinical biomarker research. Our customers, who include nine of the top ten pharmaceutical companies, trust Aushon to supply the most reliable biomarker data available, lowering costs and improving research productivity.

Aushon Contact:

Rocco Raduazo

Vice President, Sales & Marketing
1-877-AUSHON-1
E-mail: info@aushon.com


'/>"/>
SOURCE Aushon BioSystems
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
2. BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President
3. BioNeutral Group Appoints A New Member to the Board of Directors
4. Western Carolina University, College of Business Appoints New Director of Entrepreneurship and Innovation
5. JG Finneran Associates Appoints Chebios as its Exclusive Distributor in Italy
6. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
7. ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
8. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
9. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
10. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
11. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... MANASSAS, Va. , Feb. 5, 2016 ... organization, is poised to assist the medical and life ... concerns around Zika Virus infection.   CDC ... --> Zika virus is a single-stranded ... also includes the West Nile, Dengue and Chikungunya Viruses. ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)... 2016 Beike Biotechnology, the Shenzhen ... a ceremony in late 2015 to mark their successful ... 2016. --> --> ... Personalized Cell Therapy" was hosted by the Shenzhen Cell ... subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
Breaking Biology Technology:
(Date:1/11/2016)... Calif. , Jan. 11, 2016 Synaptics ... human interface solutions, today announced that its ClearPad ® ... integration (TDDI) products won two separate categories in the ... Mobile Innovator and Best Technology Breakthrough. The Synaptics ® ... cost, a simplified supply chain, thinner devices, brighter displays ...
(Date:1/8/2016)... , January 8, 2016 NXTD ... and WorldVentures ® , a privately held leading direct ... Inc. 5000 fastest-growing company announced that on ... of $2 million in Nxt-ID to develop a proprietary ... Nxt-ID,s Wocket ® , a unique smart wallet that ...
(Date:1/7/2016)... 7, 2016  A United States District Court in ... in the country to interpret a biometric privacy statute ... forward against the photo website Shutterfly brought by the law ... NORBERG vs. SHUTTERFLY, INC.; and THISLIFE, INC ( ... Shutterfly violates the Illinois Biometric Privacy Act by collecting ...
Breaking Biology News(10 mins):